DANIEL MEDINA to Antineoplastic Agents
This is a "connection" page, showing publications DANIEL MEDINA has written about Antineoplastic Agents.
Connection Strength
0.141
-
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration. J Immunother Cancer. 2019 05 22; 7(1):136.
Score: 0.078
-
BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer. Clin Cancer Res. 2016 Dec 15; 22(24):6176-6191.
Score: 0.063